ACR Meeting Abstracts

ACR Meeting Abstracts

  • Home
  • Meetings Archive
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP Annual Meeting
    • 2017 ACR/ARHP PRSYM
    • 2016-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • Register
    • View and print all favorites
    • Clear all your favorites
  • Meeting Resource Center

2016 ACR/ARHP Annual Meeting

November 11-16, 2016. Washington, DC.

View by Number View by Title View Sessions
View by Date
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
  • Abstract Number: 1491
    M-Ficolin and MAp44 As Potential Markers of Subclinical Cardiovascular Comorbidity; Cardiac Evaluation By Coronary Computer Tomography and Myocardial Deformation of Left Ventricle in Early Rheumatoid Arthritis Patients
  • Abstract Number: 1933
    M2 Macrophage Is the Predominant Phenotype in Airways Inflammatory Lesions in Patients with Granulomatosis with Polyangiitis
  • Abstract Number: 3082
    Macrophage Activation Syndrome Is Identified By Coagulopathy, Hyperferritinemia, Fever, and Cytopenia in Hospitalized Patients, Resulting in Poor Outcome
  • Abstract Number: 1462
    Magnesium Is a New Mediator Arthritis Severity and Joint Damage
  • Abstract Number: 934
    Magnetic Resonance Imaging (MRI) Joint Space Narrowing Is an Independent Predictor of Radiographic and MRI Damage Progression in Patients with Early Rheumatoid Arthritis
  • Abstract Number: 1306
    Magnetic Resonance Imaging Measures of Disease Activity in Rheumatoid Arthritis Patients Treated with Multiple Regimens of DMARD Therapy
  • Abstract Number: 1595
    Magnitude and Duration of Early Response with Tofacitinib: Post-Hoc Analysis of Two Phase 3, Placebo-Controlled Studies
  • Abstract Number: 2513
    Maintained Remission in Rheumatoid Arthritis over 7 Years in «Real Life Conditions» : A Monocentric Observational Study
  • Abstract Number: 1021
    Maintaining Sufficient Serum Vitamin D Levels over 2 Years Is Associated with Reduced Knee Structural and Symptomatic Changes in Patients with Knee Osteoarthritis
  • Abstract Number: 2124
    Maintenance of Chondrocyte Phenotypic Stability By TRPC6 Calcium Channel Activity
  • Abstract Number: 3226
    Maintenance of Clinical Remission and Radiographic Non-Progression with MTX after Completion of 1 Year Initial Treatment with Certolizumab Pegol in Japanese Patients with Early Rheumatoid Arthritis
  • Abstract Number: 594
    Maintenance of Improvements in Patients’ Physical Function, Workplace and Household Productivity, and Reduction in Caregiver Burden with 2 Years of Certolizumab Pegol Treatment in DMARD-Naive, Early RA Patients with Severe Progressive Disease
  • Abstract Number: 975
    Maintenance Therapy Improves Long-Term Outcomes in Patients with Primary Angiitis of the Central Nervous System
  • Abstract Number: 1601
    Maintenance Treatment Using Abatacept with Dose Reduction after Achievement of Low Disease Activity in Patients with Rheumatoid Arthritis (MATADOR) – a Prospective, Multicentered, Single Arm Clinical Trial
  • Abstract Number: 3024
    Major Adverse Cardiovascular Events: Risk Factors in Patients with RA Treated with Tofacitinib
  • Abstract Number: 1188
    Major Comorbidities of Idiopathic Inflammatory Myositis: A Population-Based Study Using 10 Years of Follow up from the National Health Insurance in Korea
  • Abstract Number: 1573
    Major Histocompatibility Antigen HLA-DQ6.1 (DQA1*0103/DQB1*0601) Increases Rheumatoid Arthritis Risk Independent of Shared Epitope Among Indians
  • Abstract Number: 2878
    Major Lymphocyte Populations Share a Common Interferon Signature but Express Cell Type-Specific Interferon Pathway Genes in SLE
  • Abstract Number: 2503
    Making Room for RA Patient Symptoms into Treatment Decision: A Physician Perspective Study
  • Abstract Number: 2020
    Making the Case for Self-Management Education:  Marketing Lessons Learned from Qualitative Research
  • Abstract Number: 239
    Malignancies in Korean Patients with Immunoglobulin G4-Related Disease
  • Abstract Number: 1953
    Management and Outcomes of ANCA-Associated Vasculitis in Unselected Cases within a Large Health Region of England
  • Abstract Number: 1310
    Management of Chronic Post-Chikungunya Rheumatic Disease: The Martinican Experience
  • Abstract Number: 2305
    Mapping the Topography of Gout Flares: Solutions for Flare Reporting in Gout Clinical Trials
  • Abstract Number: 1616
    Mavrilimumab, a Fully Human Granulocyte-Macrophage Colony-Stimulating Factor Receptor-α Monoclonal Antibody: Long-Term Safety and Efficacy for up to 158 Weeks of Treatment in Patients with Rheumatoid Arthritis
  • Abstract Number: 2732
    Meaningful Involvement of Patients in the Development of a Core Outcome Set for Psoriatic Arthritis
  • Abstract Number: 757
    Measures of Disease Activity in Patients with Persistently Active Systemic Lupus Erythematosus (SLE): Results from a Two-Part 52 Week Pilot Study of Repository Corticotropin Injection (H.P. Acthar® Gel)
  • Abstract Number: 138
    Measuring Agreement in the Ultrasonographic Evaluation of Disease Activity in Rheumatoid Arthritis Patients. a Latin-American Multicenter Exercise Assessing the Influence of Sonographer Experience and Expertise
  • Abstract Number: 1989
    Mechanism of STAT3 Gain-of-Function in a Patient with JIA
  • Abstract Number: 2429
    Mechanisms for the Development of Lung Fibrosis in Sting-Associated Vasculopathy with Onset in Infancy (SAVI)
  • Abstract Number: 2927
    Mechanisms Regulating the Loss of Tregs in CD11c-Flip-KO Mice That Contribute to the Spontaneous Development of Inflammatory Arthritis
  • Abstract Number: 152
    Median Nerve Stiffness Measured By Elastosonography in Patients with Rheumatoid Arthritis Is Higher Than Controls
  • Abstract Number: 2208
    Mediators of the Relationship Between Pain and Disability in the Distal Upper Limb
  • Abstract Number: 1255
    Medicare Part B Utilization By Rheumatology Health Care Providers As Related to Population Demographics from 2013
  • Abstract Number: 2393
    Medication Use in the Juvenile Systemic Sclerosis Inception Cohort.  ARE There Differences in the Diffuse and Limited Subset Patients?
  • Abstract Number: 1402
    Meeting the Needs of Adolescents with Autoimmune Diseases, the Development of a Clinical Transition Pathway
  • Abstract Number: 2993
    Membrane-Type 1 Matrix Metalloproteinase Controls Osteo- and Chondrogenesis By a Proteolysis-Independent Mechanism Mediated By Its Cytoplasmic Tail
  • Abstract Number: 2406
    Mental Health Care for Adolescents with Rheumatologic Conditions: Perspectives from Pediatric Behavioral Health Providers in North America
  • Abstract Number: 1869
    Mental Health Care in Systemic Sclerosis; Rates of Utilization and Associated Factors in the Scleroderma Patient-Centered Intervention Network Cohort
  • Abstract Number: 1141
    Mentoring the Pediatric Rheumatology Community through the American College of Rheumatology/Childhood Arthritis and Rheumatology Research Alliance Mentoring Interest Group Network: A Five-Year Status Update
  • Abstract Number: 2784
    Mesenchymal Stem Cells Ameliorate Lupus By Promoting T Cell Apoptosis Via Bcl-2/Bim Independent Pathway in MRL/Lpr Mice
  • Abstract Number: 1844
    Mesenchymal Stem Cells Ameliorate the Deficiencies in Immunomodulatory and Phagocytic Capacities of Lupus Macrophages
  • Abstract Number: 3176
    Meta-Analysis of SSc Clinical Trials with Molecular Gene Expression Data Suggests Potential Combination Therapies
  • Abstract Number: 1490
    Metabolic and Cardio-Vascular Benefits of Hydroxychloroquine in Patients with Rheumatoid Arthritis: A Systematic Review and Meta-Analysis
  • Abstract Number: 289
    Metabolic and Inflammatory Links to Development of Rotator Cuff Tear in Hand Osteoarthritis
  • Abstract Number: 1828
    Metabolic Reprogramming in CD4+CD28-CXCR3intt-bethi cells and Its Relevance to Pathogenesis in Patients with SLE
  • Abstract Number: 1542
    Metabolic Syndrome and Cardiovascular Risk Factors in Brazilian Patients with Established Rheumatoid Arthritis 
  • Abstract Number: 2168
    Metabolic Syndrome, All Cause Mortality and Atherosclerotic Cardiovascular Disease in Rheumatic Diseases
  • Abstract Number: 2532
    Methotrexate Adherence in an Online Network of Patients with Rheumatoid Arthritis
  • Abstract Number: 1676
    Methotrexate and Anti-Tumor Necrosis Treatment Improve Endothelial Function in Patients with Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
  • Abstract Number: 1315
    Methotrexate and TNF-Blockers for Post Chikungunya Chronic Arthritis : The Martinican Experience
  • Abstract Number: 2261
    Methotrexate Inhibits Intracellular Redox Signaling Induced By the Reactive Oxygen Species; Malondialdehyde and Acetaldehyde
  • Abstract Number: 1204
    Methotrexate Is an Antibacterial Drug Metabolized By Human Gut Bacteria
  • Abstract Number: 1606
    Metrotexate Treatment Inmunomodulate the Abnormal Cytokine Expression Present in NaïVe Rheumatoid Arthritis Patients
  • Abstract Number: 367
    Microarray Analyses of Dorsal Root Ganglia for the Study of Pathways Contributing to Pain in Experimental Osteoarthritis
  • Abstract Number: 2836
    Microparticles of Endothelial  Origin in  Women with   Systemic LUPUS Erythematosus UNDER Treatment
  • Abstract Number: 2414
    Microrna Associated with Active Systemic Juvenile Idiopathic Arthritis Regulate CD163 Expression in Polarized Macrophages through Two Distinct Mechanisms
  • Abstract Number: 810
    Microrna-125b As a Potential Anti-Fibrotic and Anti-Apoptotic Regulator in Systemic Sclerosis
  • Abstract Number: 1034
    Microrna-146a Controls Local Bone Destruction By Regulating Fibroblast Induced Osteoclastogenesis in Inflammatory Arthritis
  • Abstract Number: 1568
    Microrna-17 Suppresses TNF-α Signaling By Reducing TRAF2 and cIAP2 Association in Rheumatoid Arthritis Synovial Fibroblasts
  • Abstract Number: 1672
    Microrna-29a Activation of Canonical Wnt Signaling By Targeting LRP6 in Ankylosing Spondylitis
  • Abstract Number: 2997
    Microrna-29a Curtails Synovitis in the Development of Knee Osteoarthritis By Disrupting VEGF
  • Abstract Number: 2099
    Micrornas As Potential Modulators of Atherothrombosis in Antiphospholipid Syndrome
  • Abstract Number: 1666
    Micrornas Mir-30b-5p, Mir-34a-5p, and Mir-431-3p Are Highly Expressed in the Plasma of Patients with Ankylosing Spondylitis
  • Abstract Number: 809
    Micrornas Targeting the Wnt Signalling Pathway in Black African Patients with Diffuse Cutaneous Systemic Sclerosis
  • Abstract Number: 2897
    Microvascular Function in Systemic Sclerosis Patients with End-Stage Vascular Manifestations of the Disease
  • Abstract Number: 590
    Microvesicles in the Lungs of Early Rheumatoid Arthritis
  • Abstract Number: 2332
    Midterm Outcome of Modular Metal-on-Metal Total Hip Arthroplasty
  • Abstract Number: 473
    Migration, Colonization and Distribution of Bone Marrow Mesenchymal Stem Cells Transplanted in CIA Rats Were Traced By Green Fluorescent Protein
  • Abstract Number: 1056
    Mind-Body Skills Training and Supportive Counseling for Depression in SLE: Positive Effects in a Randomized Controlled Trial
  • Abstract Number: 300
    Mindfulness Predicts Treatment Response from Non-Pharmacological Therapy in Knee Osteoarthritis
  • Abstract Number: 2085
    Minding the Gap:  the Use of Nurse Practitioners and Physician Assistants in U.S. Rheumatology Practice to Affect Rheumatology Workforce Shortages
  • Abstract Number: 1765
    Minimal Clinically Important Differences for Generic Patient Reported Outcomes Tools in SLE
  • Abstract Number: 2767
    Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Evaluation of Modified Minimal Disease Activity upon Elimination of Each Component
  • Abstract Number: 2758
    Minimal Disease Activity Among Psoriatic Arthritis Patients in Canada: Which Unmet Criteria Are More Prevalent Among Responders?
  • Abstract Number: 1696
    Minimal Disease Activity Is a Stable Measure of Therapeutic Response in Psoriatic Arthritis Patients Receiving Treatment with Adalimumab
  • Abstract Number: 299
    Minimally Important Differences for Four Patient-Reported Outcomes Measurement Information System (PROMIS) Short Forms: Physical Function, Pain Interference, Depression, and Anxiety Among Adults with Knee Osteoarthritis
  • Abstract Number: 3253
    Minimum Physical Function Needed to Walk 6000 Steps/Day in People with Knee Osteoarthritis
  • Abstract Number: 249
    MiR-204-3p Associates with an Increased Level of IL-6 in Familial Mediterranean Fever By Targeting the PIK3 Signaling Pathway
  • Abstract Number: 3231
    miR200b-5p Expression in Minor Salivary Glands (MSG): A Possible Predictor of Lymphoma Development in Sjögren’s Syndrome (SS)?
  • Abstract Number: 3075
    Mitochondrial Genetic Variation, Copy Number and Susceptibility to Gout in the New Zealand Polynesian Population
  • Abstract Number: 2492
    Mode of Administration in Rheumatoid Arthritis Treatments: An Exploration of Patient Preference for an ‘Ideal Treatment’
  • Abstract Number: 1862
    Modelling Healthy and Scleroderma Fibrotic Skin in Vitro: Mechanical Stress Alters Macrophage Cytokine Expression and Triggers Signalling Via the Mechano-Sensing Transcription Factor Myocardin-Related Transcription Factor-a
  • Abstract Number: 3227
    Modelling Primary Sjögren’s Syndrome Using Salivary Gland Stem Cells
  • Abstract Number: 1861
    Modelling the Interaction Between Disease Microenvironment and Mesenchymal Cells in Systemic Sclerosis
  • Abstract Number: 2230
    Models Using Claims-Based Administrative Data Are Poor Predictors of Rheumatoid Arthritis Disease Activity in VA Rheumatoid Arthritis (VARA) Patients
  • Abstract Number: 1470
    Moderate to Severe Disease Activity in Rheumatoid Arthritis  Is Associated with Myocardial  18f-Fluorodeoxyglucose (18F-FDG) Uptake
  • Abstract Number: 24
    Modifiable Rheumatoid Arthritis Factors and Impact on Cardiovascular Risk
  • Abstract Number: 1461
    Modification of Proteins with Malondialdehyde-Acetaldehyde and Citrulline Elicit Antibody Responses in DBA/1J Mice
  • Abstract Number: 2697
    Modulator Role of Inducible Costimulator (ICOS) in Spondyloarthritis Animal Model
  • Abstract Number: 432
    Monitoring Hepatitis B Screening Compliance in Patients with Rheumatoid Arthritis (RA) Receiving Anti-TNF Therapy
  • Abstract Number: 812
    Monocytes/Neurotrophins/Myofibroblasts As a Novel Axis in Systemic Sclerosis
  • Abstract Number: 2280
    Monosodium Urate Crystal-Induced Inflammation Promotes Osteocyte Expression of Pro-Resorptive and Inflammatory Mediators: Implications for Erosive Gout
  • Abstract Number: 2281
    Monosodium Urate Monohydrate (MSU) Crystals Induces Cartilage Degeneration By Accelerating Hypertrophy and Mineralization.
  • Abstract Number: 1614
    Monotherapy with Abatacept, Rituximab or Tocilizumab Is Not Associated with a Significantly Lower Long Term Retention Than Combination with Synthetic DMARD: Long-Term Registry Data in 4498 Real-Life Patients with Rheumatoid Arthritis
  • Abstract Number: 1170
    Month of Birth Affects the Risk of Rheumatic Diseases: A Nationwide Case-Control Study
  • Abstract Number: 1026
    Morphea-like Skin Lesions Reported in the Phase 3 Long-Term Odanacatib Fracture Trial and Extension in Postmenopausal Women with Osteoporosis
  • Abstract Number: 1351
    Mortality and Prognostic Factors of Pneumocystis Pneumonia in Patients with Connective Tissue Diseases
  • Abstract Number: 1192
    Mortality and Survival of Patients Diagnosed with GCA in Bergen (Western Norway) 1972-2012
  • Abstract Number: 1250
    Mortality in Indigenous Populations of Canada, the United States, Australia, and New Zealand with Rheumatic Disease: A Systematic Review
  • Abstract Number: 3065
    Mortality in Patients with Rheumatoid Arthritis and Interstitial Lung Disease Treated with First Line TNFi or Rituximab Therapies
  • Abstract Number: 523
    Mortality Profile of Patients with Rheumatoid Arthritis in France and Its Change in 10 Years
  • Abstract Number: 1193
    Mortality Rate According to Cause in Patients with Hemophagocytic Lymphohistiocytosis: A Meta-Analysis
  • Abstract Number: 3169
    Mortality Trends in Systemic Lupus Erythematosus: A General Population-Based Cohort Study
  • Abstract Number: 1931
    MRI Findings in Granulomatosis with Polyangiitis: Pachymeningitis and Implications in Quality of Life
  • Abstract Number: 1308
    MRI of Bilateral Hands Prevents Clinicians from Failing to Detect Joint Damage of Patients with Rheumatoid Arthritis Compared to Scanning Unilateral Hand
  • Abstract Number: 306
    MRI-Detected Cartilage Damage, Meniscal Damage, and Meniscal Extrusion Prior to Incident Radiographic Osteoarthritis and the Subsequent Trajectory of Joint Space Loss
  • Abstract Number: 1300
    MRI-Detected Inflammation Is Associated with Functional Disability in Early Arthritis – Results of a Cross-Sectional Study
  • Abstract Number: 579
    MRI-Detected Osteitis Is Not Associated with the Presence or Level of ACPA Alone, but with the Combined Presence of ACPA and RF
  • Abstract Number: 256
    Muckle-Wells Syndrome in Chinese Adult Patients
  • Abstract Number: 2401
    Mucocutaneous Lesions and Recurrent Fevers in Patients with Trisomy 8 Mosaicism and Chromosome 8 Duplication
  • Abstract Number: 2520
    Multi-Biomarker Disease Activity (MBDA) Score and Prediction of Radiographic Progression in a Randomized Study of Patients with Early RA Treated with Methotrexate Alone or with Adalimumab
  • Abstract Number: 2798
    Multi-Center Validation of Platelet Bound C4d, a Biomarker for Systemic Lupus Erythematosus
  • Abstract Number: 803
    Multi-Organ RNA-Sequencing of Systemic Sclerosis (SSc) Patients Shows Reproducible Gene Expression Profiles Across Organ Systems
  • Abstract Number: 793
    Multi-Parametric Model Development for Assessing Lupus Nephritis and Disease Activity
  • Abstract Number: 801
    Multi-Tissue Gene Expression Pathway Analysis of Emerging Therapeutics in a TGFβ Dependent Mouse Model of Systemic Sclerosis
  • Abstract Number: 1380
    Multicenter Prospective Study on the Role of Urinary HER2 As a Lupus Nephritis Biomarker
  • Abstract Number: 2411
    Multiple Genetic Susceptibility Loci in Juvenile Idiopathic Arthritis Are Bound By a Set of Transcription Factors
  • Abstract Number: 1986
    Murine Model of Arthritis Flare Identifies Tissue Resident Memory T Cells in Recurrent Synovitis
  • Abstract Number: 2405
    Musculoskeletal Manifestations As Presenting Symptoms of Inflammatory Bowel Disease in Children and Adolescents
  • Abstract Number: 1325
    Musculoskeletal Manifestations in Ebola Survivors
  • Abstract Number: 1710
    Musculoskeletal Symptoms Preceding the Diagnosis of Psoriatic Arthritis – a Qualitative Exploration of the Patient Journey
  • Abstract Number: 158
    Musculoskeletal Ultrasound Is a Sensitive Imaging Tool for the Assessment of Dynamic Changes of Bone Erosions in Inflammatory Arthritis: A Comparative Analysis with High-Resolution Peripheral Quantitatve Computed Tomography
  • Abstract Number: 2271
    Mutation in Osteoprotegerin Gene: Early-Onset Osteoarthritis and Chondrocalcinosis in a US Family of Italian/German Ancestry
  • Abstract Number: 2430
    Mutations in the Tyrosine-Protein Kinase Lyn Cause an Early-Onset Neutrophilic Vasculitis Syndrome
  • Abstract Number: 1824
    Mycophenolate Mofetil Use Associates with Unique Biologic Changes in B Cell and T Regulatory Cell Pathways in SLE Patients
  • Abstract Number: 824
    Mycophenolate Versus Placebo for the Treatment of Systemic Sclerosis-Related Interstitial Lung Disease
  • Abstract Number: 1393
    Mycophenolic Acid Pharmacokinetics in Childhood-Onset Systemic Lupus Erythematosus Patients of Hispanic Ethnicity in a Single Center
  • Abstract Number: 6L
    Myeloablative Autologous Transplantation of CD34+ -Selected Hematopoietic Stem Cells (HSCT) Vs Monthly Intravenous Cyclophosphamide (CYC) for Severe Scleroderma with Internal Organ Involvement: Outcomes of a Randomized North American Clinical Trial
  • Abstract Number: 1471
    Myocardial 18f-Fluorodeoxyglucose (18F-FDG) Uptake in RA Patients without Clinical Cardiovascular Disease Is Higher Than in Controls and Decreases with Treatment
  • Abstract Number: 2055
    Myocardial Abnormalities Are Associated with Corrected QT Interval in Patients with Rheumatoid Arthritis without Cardiac Symptoms Assessed Using Cardiac Magnetic Resonance Imaging
  • Abstract Number: 1494
    Myocardial Structure, Function, and Fibrosis in Patients with Rheumatoid Arthritis and Matched Control Subjects
  • Abstract Number: 1819
    Myocarditis in Systemic Lupus Erythematosus
Jump to:  View All • a b c d e f g h i j k l [m] n o p q r s t u v w x y z
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

ACR Convergence: Where Rheumatology Meets. All Virtual. November 5-9.

ACR Pediatric Rheumatology Symposium 2020

© COPYRIGHT 2021 AMERICAN COLLEGE OF RHEUMATOLOGY

Wiley

  • Home
  • Meetings Archive
  • Advanced Search
  • Meeting Resource Center
  • Online Journal
  • Privacy Policy
  • Permissions Policies
This site uses cookies: Find out more.